Business Description
aXichem AB
ISIN : SE0005250719
Share Class Description:
OSTO:AXIC A: Class ATotal Employee Number:
7Compare
Compare
Traded in other countries / regions
AXIC A.SwedenA6X.Germany IPO Date
2011-03-04Description
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.83 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 19.23 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2 | |||||
3-Year EBITDA Growth Rate | 30.9 | |||||
3-Year EPS without NRI Growth Rate | 33.3 | |||||
3-Year FCF Growth Rate | 40.3 | |||||
3-Year Book Growth Rate | -27.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.77 | |||||
9-Day RSI | 33.92 | |||||
14-Day RSI | 38.68 | |||||
3-1 Month Momentum % | 174.33 | |||||
6-1 Month Momentum % | 192.24 | |||||
12-1 Month Momentum % | -9.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.5 | |||||
Quick Ratio | 2.29 | |||||
Cash Ratio | 0.69 | |||||
Days Inventory | 365.68 | |||||
Days Sales Outstanding | 79.68 | |||||
Days Payable | 60.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -50.5 | |||||
Shareholder Yield % | 1.12 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 50.88 | |||||
Operating Margin % | -94.23 | |||||
Net Margin % | -95.37 | |||||
EBITDA Margin % | -63.06 | |||||
FCF Margin % | -48.87 | |||||
OCF Margin % | -48.87 | |||||
ROE % | -27.06 | |||||
ROA % | -24.22 | |||||
ROIC % | -25.63 | |||||
3-Year ROIIC % | 47.75 | |||||
ROC (Joel Greenblatt) % | -367.69 | |||||
ROCE % | -26.73 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 8.32 | |||||
PB Ratio | 2.67 | |||||
Price-to-Tangible-Book | 13.63 | |||||
EV-to-EBIT | -9.49 | |||||
EV-to-EBITDA | -14.18 | |||||
EV-to-Revenue | 8.94 | |||||
EV-to-FCF | -16.93 | |||||
Price-to-GF-Value | 0.87 | |||||
| Price-to-Net-Current-Asset-Value | 14.53 | |||||
Earnings Yield (Greenblatt) % | -10.54 | |||||
FCF Yield % | -5.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
aXichem AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 16.267 | ||
| EPS (TTM) (kr) | -0.249 | ||
| Beta | -3.4725 | ||
| 3-Year Sharpe Ratio | 0.25 | ||
| 3-Year Sortino Ratio | 0.5 | ||
| Volatility % | 143.06 | ||
| 14-Day RSI | 38.68 | ||
| 14-Day ATR (kr) | 0.36523 | ||
| 20-Day SMA (kr) | 2.6935 | ||
| 12-1 Month Momentum % | -9.85 | ||
| 52-Week Range (kr) | 1.135 - 4.070289 | ||
| Shares Outstanding (Mil) | 67.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
aXichem AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
aXichem AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-25 | In 175 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-26 | In 84 days | ||
| Third quarter earnings results for 2026 | 2026-11-26 | In 84 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-27 | 2.69 (+2.28%) | ||
| Second quarter earnings results for 2026 | 2026-08-27 | 2.69 (+2.28%) | ||
| General meeting for 2026 | 2026-06-17 10:00 | 1.28 (+0.39%) | ||
| Annual report for 2025 | 2026-05-27 | 1.47 (-2.00%) | ||
| First quarter earnings results for 2026 | 2026-05-21 | 1.50 (-2.29%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 1.23 (+4.26%) | ||
| Third quarter earnings conference call for 2025 | 2025-11-28 14:00 | 2.30 (-2.52%) |
Show
Entries
aXichem AB Frequently Asked Questions
What is aXichem AB(OSTO:AXIC A)'s stock price today?
The current price of OSTO:AXIC A is kr2.18. The 52 week high of OSTO:AXIC A is kr4.07 and 52 week low is kr1.14.
When is next earnings date of aXichem AB(OSTO:AXIC A)?
The next earnings date of aXichem AB(OSTO:AXIC A) is 2026-11-26.
Does aXichem AB(OSTO:AXIC A) pay dividends? If so, how much?
aXichem AB(OSTO:AXIC A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on aXichem AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers